Emma Walmsley, GSK CEO

GSK touts record Shin­grix sales as Zan­tac cas­es go to tri­al

Months af­ter GSK changed its name from Glax­o­SmithK­line and spun off its con­sumer health di­vi­sion in­to the stand­alone Ha­le­on, the Big Phar­ma is re­port­ing bet­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.